Genedata announces that it has scaled-up its collaboration in high throughput screening (HTS) analysis with Novartis Institutes for Biomedical Research (NIBR). Genedata’s new agreement with Novartis includes round the clock support for the Genedata Screener® platform in Cambridge (MA), USA and Basel, Switzerland.
